ArticleChemotherapy2024

Long-Term Progression-Free Survival of a Pre-Treated Patient with Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil.

Gerlinde Maria Michl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.